NCCN updates myeloma guidelines, names clonoSEQ for MRD testing
Adaptive Biotechnologies (Nasdaq: ADPT) announced that the National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines in Oncology ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

